Do neurooncological patients and their significant others agree on quality of life ratings?
暂无分享,去创建一个
Bernhard Holzner | Gerhard Rumpold | Georg Kemmler | G. Kemmler | J. Giesinger | G. Rumpold | B. Holzner | Markus Hutterer | Astrid Erharter | Gabriele Schauer-Maurer | Guenter Stockhammer | Armin Muigg | M. Hutterer | Johannes M Giesinger | Miriam Golser | A. Muigg | M. Golser | A. Erharter | Gabriele Schauer-Maurer | G. Stockhammer
[1] P J Nichols,et al. Functional Assessment , 2019, The SAGE Encyclopedia of Human Communication Sciences and Disorders.
[2] J. Varni,et al. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core Scales , 2007, Health and quality of life outcomes.
[3] R. Arusell,et al. A Prospective Study of Quality of Life in Adults With Newly Diagnosed High-Grade Gliomas: Comparison of Patient and Caregiver Ratings of Quality of Life , 2008, American journal of clinical oncology.
[4] K. Stein,et al. Temozolomide for high grade glioma. , 2008, The Cochrane database of systematic reviews.
[5] Galina Velikova,et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[7] Bernhard Holzner,et al. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. , 2010, Journal of pain and symptom management.
[8] M. Prados,et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. , 2003, Neuro-oncology.
[9] J. Olson,et al. Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life. , 2005, Cancer investigation.
[10] Mohamed Abdolell,et al. Perception of quality of life by patients, partners and treating physicians , 2004, Quality of Life Research.
[11] L. Carlson,et al. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients , 2000, Psycho-oncology.
[12] D. Osoba,et al. The use of significant others as proxy raters of the quality of life of patients with brain cancer. , 1997, Medical care.
[13] N. Aaronson,et al. The Influence of Proxy Perspective on Patient-Proxy Agreement in the Evaluation of Health-Related Quality of Life: An Empirical Study , 2008, Medical care.
[14] N. Aaronson,et al. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. , 1998, Journal of clinical epidemiology.
[15] Susie A. Sami,et al. Health State Valuation in Mild to Moderate Cognitive Impairment: Feasibility of Computer-Based, Direct Patient Utility Assessment , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] C. O'boyle,et al. Proxy assessment of quality of life in patients with prostate cancer: how accurate are partners and urologists? , 2008, Journal of the Royal Society of Medicine.
[17] M. Hegel,et al. Proxy perspectives regarding end‐of‐life care for persons with cancer , 2008, Cancer.
[18] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[20] M. King. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.
[21] D. Cella,et al. The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors , 1995, Cancer.
[22] G. Kempen,et al. Patients' self-report and family caregivers' perception of quality of life in patients with advanced cancer: how do they compare? , 2006, European journal of cancer care.
[23] D. Osoba,et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires , 1996, Quality of Life Research.